Can B Corp. revenue by segment NASC

Annual Quarterly

Can B Corp. splits its revenue into 2 lines in its filings. The largest line in fiscal 2023, which ended Dec 31, 2023 was Product at $1.3 million, 62% of the total.

USD in millions. The percent under a figure is the change from the year before.

FY 2024
Sep 30, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
FY 2019
Dec 31, 2019
FY 2018
Dec 31, 2018
FY 2017
Dec 31, 2017
FY 2016
Dec 31, 2016
Revenue
1
2
7
5
2
2
1
0
0
Product
—
1
-75.8%
share 62.0%
6
+32.9%
share 82.6%
4
+143.3%
share 90.3%
2
share 99.9%
—
—
—
—
Services
—
1
-29.4%
share 38.0%
1
+159.5%
share 17.4%
0
+35703.8%
share 9.7%
0
share 0.1%
—
—
—
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Wholesale-Drugs, Proprietaries & Druggists' Sundries (SIC 5122)
Listed as
NASC (OTC)
Fiscal year ends
December 31
Incorporated in
FL
Headquarters
Hicksville, NY
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1509957
Former names
Canbiola, Inc. (until Mar 3, 2020); Wrapmail, Inc. (until May 15, 2017)

Other Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

All 11 Wholesale-Drugs, Proprietaries & Druggists' Sundries companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.